Alzheimer’s disease and transgenic mice
Transgenic mice overexpressing the three major neuronal isoforms of the human amyloid precursor protein (APP), APP695, APP751, APP770 may provide an animal model for the analysis of the mechanisms and risk factors leading to amyloid deposition in Alzheimer’s disease (AD) and Downs syndrome (DS). We have therefore generated transgenic mice expressing these isoforms under the control of the strong metallothionin promoter. Although we can demonstrate expression of transgenic APP in several tissues including brain, expression levels never exceeded those of the endogenous mouse APP. So far we have not been able to detect pathological changes resembling those of AD and DS. However we could demonstrate significant changes in spatial navigation tasks and motor behavior in the transgenic mice. The question remains open whether overexpression of APP is sufficient to induce Alzheimer pathology.
KeywordsDowns Syndrome Human Amyloid Precursor Protein Spatial Navigation Task Human APP695
Unable to display preview. Download preview PDF.
- Banati RB, Gehrmann J, Czech C, Mönning U, Jones LL, König G, Masters CL, Beyreuther K, Kreutzberg GW (1993) Early and rapid denovo synthesis of Alzheimer βA4 amyloid precursor protein (APP) in activated mircoglia. Glia 9: 199–210Google Scholar
- Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38: 1688–1693PubMedGoogle Scholar
- Glenner GG, Wong (1984) Alzheimer’s disease: inital report of the purification and characterisation of a novel cerebrovascular amyloid protein. C.M. Biochem Biophys Res Commun 120: 885Google Scholar
- Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL, Neve RL (1992) Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 89: 10857–10861PubMedCrossRefGoogle Scholar
- Kang J, Muller HB (1990) Differential splicing of Alzheimer’s disease amyloid A4 precursor RNA in rat tissues: Pre A4 (695) RNA is predominantly produced in rat and human brain. Biochem Biophys Res Commun 166: 1192–1200Google Scholar
- Kawabata S, Higgins GA, Gordon JW (1991) Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein [retracted by Kawabata S, Higgins GA, Gordon JW. In: Nature 356: 23 (1992) and Nature 356: 265 (1992) [see comments]. Nature 354: 476–478Google Scholar
- König G, Mönning U, Czech C, Prior R, Banati R, Schreiter GU, Bauer J, Masters CL, Beyreuther K (1992) Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem 267: 10804–10809PubMedGoogle Scholar
- Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4: 2757–2763Google Scholar
- Sandbrink R, Master CL, Beyreuther K (1994) 0A4-Amyloid protein precursor mRNA isoforms without exon 15 ( L-APP mRNAs) are ubiquitously expressed in rat tissues including brain, but not in neurons. J Cell Biol 261: 1510–1517Google Scholar